Please login to the form below

Not currently logged in
Email:
Password:

Sir Andrew Witty

This page shows the latest Sir Andrew Witty news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more

Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more

The Accelerated Access Collaborative (AAC) was meant to have started work in April, but since former GSK chief executive Sir Andrew Witty stepped down as its chair, the initiative has been ... I’m thrilled to be building on the great foundations laid

Latest news

  • Ex-GSK CEO Witty named head of pharmacy benefit firm Optum Ex-GSK CEO Witty named head of pharmacy benefit firm Optum

    Ex-GSK CEO Witty named head of pharmacy benefit firm Optum. Current Optum CEO Larry Renfro will move to Optum Ventures as MD. ... Former GlaxoSmithKline chief executive Andrew Witty has been named as the new head of UnitedHealth’s pharmacy benefit

  • Ex-GSK head Witty to head group overseeing UK fast-track scheme Ex-GSK head Witty to head group overseeing UK fast-track scheme

    Ex-GSK head Witty to head group overseeing UK fast-track scheme. Medicines selected for the AAP could be made available much earlier. ... The UK government’s efforts to accelerate the approval of important new medicinal therapies will be headed by Sir

  • GSK’s R&D head Vallance departs, possibly for government role GSK’s R&D head Vallance departs, possibly for government role

    group under new chief executive Emma Walmsley, who took over from previous CEO Sir Andrew Witty in April. ... The last two incumbents, including current chief scientific advisor Professor Sir Mark Walpole who is not due to leave the role until next year,

  • Walmsley steps up to chief executive role at GSK Walmsley steps up to chief executive role at GSK

    Walmsley steps up to chief executive role at GSK. The firm's first female CEO, she takes over from Sir Andrew Witty. ... Emma Walmsley is due to take over as chief executive of GlaxoSmithKline (GSK) today as Sir Andrew Witty officially steps down from

  • GSK's Witty ends on a high, but warns 2017 looking 'uncertain' GSK's Witty ends on a high, but warns 2017 looking 'uncertain'

    Sir Andrew Witty's last results presentation as chief executive of GlaxoSmithKline was a good one, with the UK drugmaker beating analysts' expectations thanks to a good performance for HIV and ... This is a situation that is bound to evolve during the

More from news
Approximately 6 fully matching, plus 64 partially matching documents found.

Latest appointments

  • Former GSK CEO joins Synthego’s advisory board Former GSK CEO joins Synthego’s advisory board

    Former GSK CEO joins Synthego’ s advisory board. Sir Andrew Witty will expand the team’s bioinformatics expertise. ... Genome engineering solutions provider Synthego has appointed Sir Andrew Witty to its advisory board, a role that will see him work

  • Former RBS head takes the reins as GSK chair Former RBS head takes the reins as GSK chair

    This week Sir Philip backed GSK's under fire CEO Sir Andrew Witty, who has weathered a tough two years of scandals and continually falling sales. ... He said: “[Sir] Andrew has the complete support of the board.

  • Ex Sanofi boss joins Boston start-up Ex Sanofi boss joins Boston start-up

    He was one of several senior management staffers in-line to take GSK's top job, but ultimately lost out to Sir Andrew Witty in 2008, prompting his move to the

  • Sir Christopher Gent 'stepping down' as GSK chair Sir Christopher Gent 'stepping down' as GSK chair

    Sir Christopher Gent 'stepping down' as GSK chair. He will leave the pharma firm in the next two or three years, according to a UK press report. ... He also appointed Sir Andrew Witty as CEO in 2008 following the departure of Jean-Pierre Garnier.

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics